logo

Arcus Biosciences Inc (RCUS) Stock: Exploring a Year of Highs, Lows, and Trading Volume

ALXO Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Arcus Biosciences Inc’s current trading price is -56.04% away from its 52-week high, while its distance from the 52-week low is -4.76%. The stock’s price range over this period has fluctuated between $8.82 and $19.11. The company, operating within the financial sector, had a trading volume of approximately 0.72 million for the day, which was noticeably lower than the average daily share volume of 0.93 million over the last 3 months.

Arcus Biosciences Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $19.11 on 03/28/24, while the lowest price for the same period was registered at $8.82 on 03/25/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Arcus Biosciences Inc (RCUS) has experienced a quarterly decline of -45.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 889.06M and boasts a workforce of 627 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 13.65, with a change in price of -8.26. Similarly, Arcus Biosciences Inc recorded 857,362 in trading volume during the last 100 days, posting a change of -49.58%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RCUS stands at 0.33. Similarly, the long-term debt-to-equity ratio is also 0.30.

RCUS Stock Stochastic Average

Today’s raw stochastic average for Arcus Biosciences Inc over the last 50 days is 1.45%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 2.67%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 5.79% and 7.02%, respectively.

RCUS Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -43.59%.However, over the last six months, we can see a stronger performance of -49.03%. Over the last 30 days, the price of RCUS has leaped by -17.32%. And in the last five days, it has fallen by -6.56%.

Most Popular